Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Behavioral effects of dopaminergic agonists in transgenic mice overexpressing human wildtype alpha-synuclein.

Neuroscience - 3 Nov 2006

Fleming S M, Salcedo J, Hutson C B, Rockenstein E, Masliah E, Levine M S, Chesselet M-F

Abstract excerpt

Overexpression of alpha-synuclein causes familial Parkinson's disease and abnormal aggregates of the protein are present in sporadic cases of the disease. We have examined the behavioral effects of direct and indirect dopaminergic agonists in transgenic mice expressing human alpha-synuclein under...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to alpha-Synuclein
Share to Amphetamine
Share to Behavior, Animal

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dopamine Agonists

Share to Dose-Response Relationship, Drug

Share to Dyskinesia, Drug-Induced

Share to Mice, Transgenic

Share to Parkinson Disease

Source

Open in PubMed Open full text

Identifiers

PMID: 16934409
DOI: 10.1016/j.neuroscience.2006.07.005
PMCID: PMC3108485

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-16934409-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Behavioral effects of dopaminergic agonists in transgenic mice overexpressing human wildtype alpha-synuclein.PMID 16934409Read ↗

Behavioral and neurochemical effects of wild-type and mutated human alpha-synuclein in transgenic mice.Semantic proximity Read ↗

Effects of pharmacological agents upon a transgenic model of Parkinson's disease in Drosophila melanogaster.Semantic proximity Read ↗

Behavioural and dopaminergic changes in double mutated human A30P*A53T alpha-synuclein transgenic mouse model of Parkinson´s diseaseSemantic proximity Read ↗

Modeling Parkinson's disease‐related symptoms in alpha‐synuclein overexpressing miceSemantic proximity Read ↗

Locomotor hyperactivity and alterations in dopamine neurotransmission are associated with overexpression of A53T mutant human alpha-synuclein in mice.Semantic proximity Read ↗

α-Synuclein BAC transgenic mice as a model for Parkinson's disease manifested decreased anxiety-like behavior and hyperlocomotionSemantic proximity Read ↗

Risk factors for dopaminergic neuron loss in human α‐synuclein transgenic miceSemantic proximity Read ↗

Neuronal expression of familial Parkinson's disease A53T α-synuclein causes early motor impairment, reduced anxiety and potential sleep disturbances in mice.Semantic proximity Read ↗

The novel adaptive rotating beam test unmasks sensorimotor impairments in a transgenic mouse model of Parkinson's disease.Semantic proximity Read ↗

Pathological Changes in Dopaminergic Nerve Cells of the Substantia Nigra and Olfactory Bulb in Mice Transgenic for Truncated Human α-Synuclein(1–120): Implications for Lewy Body DisordersSemantic proximity Read ↗

Alpha-Synuclein transgenic mice, h-α-SynL62, display α-Syn aggregation and a dopaminergic phenotype reminiscent of Parkinson's disease.Semantic proximity Read ↗

Mice expressing the A53T mutant form of human alpha-synuclein exhibit hyperactivity and reduced anxiety-like behavior.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.